Viewing Study NCT03903406

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-26 @ 11:00 AM

Ignite Modification Date: 2026-03-04 @ 10:59 AM

Study NCT ID: NCT03903406

Status: UNKNOWN

Last Update Posted: 2019-04-04

First Post: 2019-04-01

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Quality of Life, Symptoms and Treatment Satisfaction in Adult Patients With Relapsed and/or Refractory Multiple Myeloma, Receiving Ixazomib (Ninlaro®) in Combination With Lenalidomide and Dexamethasone in a Real World Setting: Pilot Study

Sponsor: Multinational Center for Quality of Life Research, Russia

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module